Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2332839
Max Phase: Preclinical
Molecular Formula: C22H30N8O7
Molecular Weight: 518.53
Molecule Type: Protein
Associated Items:
ID: ALA2332839
Max Phase: Preclinical
Molecular Formula: C22H30N8O7
Molecular Weight: 518.53
Molecule Type: Protein
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CNC(=O)C[C@@H](C(=O)O)NC(=O)[C@@H](c2ccccc2)NC(=O)CNC1=O
Standard InChI: InChI=1S/C22H30N8O7/c23-22(24)25-8-4-7-13-19(34)27-11-17(33)30-18(12-5-2-1-3-6-12)20(35)29-14(21(36)37)9-15(31)26-10-16(32)28-13/h1-3,5-6,13-14,18H,4,7-11H2,(H,26,31)(H,27,34)(H,28,32)(H,29,35)(H,30,33)(H,36,37)(H4,23,24,25)/t13-,14-,18+/m0/s1
Standard InChI Key: ZPLWVCHCWZALGS-SUNYJGFJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 518.53 | Molecular Weight (Monoisotopic): 518.2237 | AlogP: -3.20 | #Rotatable Bonds: 6 |
Polar Surface Area: 244.70 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.61 | CX Basic pKa: 12.85 | CX LogP: -5.65 | CX LogD: -5.65 |
Aromatic Rings: 1 | Heavy Atoms: 37 | QED Weighted: 0.10 | Np Likeness Score: 0.74 |
1. Bochen A, Marelli UK, Otto E, Pallarola D, Mas-Moruno C, Di Leva FS, Boehm H, Spatz JP, Novellino E, Kessler H, Marinelli L.. (2013) Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids., 56 (4): [PMID:23362923] [10.1021/jm301221x] |
Source(1):